Interaction Studies Between Levodopa and Different Excipients to Develop Coground Binary Mixtures for Intranasal Application
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (8) , 2552-2560
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Human Capacities
This publication has 26 references indexed in Scilit:
- Studies of the Rate Constant of l-DOPA Oxidation and Decarboxylation by HPLCChromatographia, 2012
- Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s diseaseCurrent Medical Research and Opinion, 2011
- Levodopa delivery systems: advancements in delivery of the gold standardExpert Opinion on Drug Delivery, 2010
- Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systemsEuropean Journal of Pharmaceutical Sciences, 2009
- The scientific and clinical basis for the treatment of Parkinson disease (2009)Neurology, 2009
- Potential use of tight junction modulators to reversibly open membranous barriers and improve drug deliveryBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Brain uptake of an anti-ischemic agent by nasal administration of microparticlesJournal of Pharmaceutical Sciences, 2008
- Current approaches to the treatment of Parkinson’s diseaseNeuropsychiatric Disease and Treatment, 2008
- Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectivesAdvanced Drug Delivery Reviews, 2005
- Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessationJournal of Controlled Release, 2002